Long term safety and efficacy of H1N1 vaccine in a single-center cohort of IBD patients treated with immunomodulators and/or anti-TNFα biologics

J Crohns Colitis. 2012 Mar;6(2):264-5. doi: 10.1016/j.crohns.2011.12.004. Epub 2011 Dec 29.

Authors

Nikolaos Kyriakos, Konstantinos Papamichael, Emmanuel Archavlis, George Agalos, Gerassimos J Mantzaris

PMID: 22325186
DOI: 10.1016/j.crohns.2011.12.004

No abstract available

Publication types

Letter

MeSH terms

Cohort Studies
Colitis, Ulcerative / drug therapy
Crohn Disease / drug therapy
Fatigue / etiology
Fever / etiology
Headache / etiology
Humans
Immunosuppressive Agents / therapeutic use
Influenza A Virus, H1N1 Subtype / immunology*
Influenza Vaccines / adverse effects*
Influenza, Human / prevention & control*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Immunosuppressive Agents
Influenza Vaccines
Tumor Necrosis Factor-alpha